Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019
Journal of The Association of Physicians of India · 2024
DOI: 10.59556/japi.72.0613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Association of Physicians of India, 2024. Verfasst von Amit Goyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Senior Consultant, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India, Corresponding Author. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin M. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Senior Consultant, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India, Corresponding Author.
- Principal Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India.
- Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India.
Zitieren
APA
Goyal, A., Singh, O., & Juneja, D. (2024). Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0613
Vancouver
Goyal A, Singh O, Juneja D. Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0613
BibTeX
@article{Goyal2024,
author = {Goyal, Amit and Singh, Omender and Juneja, Deven},
title = {Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019},
journal = {Journal of The Association of Physicians of India},
year = {2024},
doi = {10.59556/japi.72.0613}
}
EUVIMED